Etomidate for anesthetic induction may cause minimal changes in systemic hemodynamics in TBI, finds Study

Written By :  Dr Monish Raut
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-09-10 01:30 GMT   |   Update On 2024-09-10 07:20 GMT

Maintaining optimal cerebral perfusion and oxygenation following anesthetic induction is crucial for preventing secondary brain insults in vulnerable acute brain injury patients and is a primary goal in the neurosurgical management of traumatic brain injury. Recent observational study compared the effects of three different anesthetic induction agents - etomidate, thiopental, and propofol - on systemic hemodynamics, regional cerebral oxygenation (rScO2), and serum cortisol levels in patients with acute traumatic brain injury (TBI).

Advertisement

The key findings of the study were: 1. Hemodynamic changes: Etomidate induction resulted in the least hemodynamic changes, with a significant decrease in mean arterial pressure (MAP) and heart rate (HR) observed with thiopental and propofol induction compared to etomidate. 2. Cerebral oxygenation: All three induction agents led to a significant increase in bilateral rScO2 after induction. The increase in contralateral rScO2 was maximal with etomidate compared to propofol. The trend changes in bilateral rScO2 were comparable between thiopental and etomidate. 3. Serum cortisol: An insignificant decrease in serum cortisol levels was observed with etomidate and thiopental, while a significant increase was seen with propofol at 24 hours post-induction. 4. Neurological outcome: The Glasgow Coma Scale (GCS) score improved significantly in all three groups at discharge, with no significant differences between the groups. In conclusion, in patients with acute TBI, anesthetic induction with etomidate resulted in the most stable hemodynamics and maximal increase in cerebral oxygenation compared to thiopental and propofol. Additionally, etomidate showed an insignificant impact on serum cortisol levels. The neurological outcome at discharge was comparable across the three induction agents.

Key Points -

Here are the 6 key points from the scientific article:

1. Hemodynamic changes: Etomidate induction resulted in the least hemodynamic changes, with a significant decrease in mean arterial pressure (MAP) and heart rate (HR) observed with thiopental and propofol induction compared to etomidate.

2. Cerebral oxygenation: All three induction agents led to a significant increase in bilateral regional cerebral oxygenation (rScO2) after induction. The increase in contralateral rScO2 was maximal with etomidate compared to propofol. The trend changes in bilateral rScO2 were comparable between thiopental and etomidate.

3. Serum cortisol: An insignificant decrease in serum cortisol levels was observed with etomidate and thiopental, while a significant increase was seen with propofol at 24 hours post-induction.

4. Neurological outcome: The Glasgow Coma Scale (GCS) score improved significantly in all three groups at discharge, with no significant differences between the groups.

5. Conclusion: In patients with acute traumatic brain injury (TBI), anesthetic induction with etomidate resulted in the most stable hemodynamics and maximal increase in cerebral oxygenation compared to thiopental and propofol.

6. Conclusion: Additionally, etomidate showed an insignificant impact on serum cortisol levels. The neurological outcome at discharge was comparable across the three induction agents.

Reference –

Sharma KK, Surve RM, Reddy KRM, Christopher R, Chakrabarti D, Pandarisamy S, et al. Impact of anesthetic induction with etomidate, thiopentone, and propofol on regional cerebral oxygenation: An observational study in patients with traumatic brain injury. J Anaesthesiol Clin Pharmacol 2024. DOI:10.4103/joacp.joacp_315_23.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News